KR20070089701A - 베클로메타손 디프로피오네이트 및 프레드니손을 이용한이식편대숙주병 및 백혈병의 치료 - Google Patents

베클로메타손 디프로피오네이트 및 프레드니손을 이용한이식편대숙주병 및 백혈병의 치료 Download PDF

Info

Publication number
KR20070089701A
KR20070089701A KR1020077013835A KR20077013835A KR20070089701A KR 20070089701 A KR20070089701 A KR 20070089701A KR 1020077013835 A KR1020077013835 A KR 1020077013835A KR 20077013835 A KR20077013835 A KR 20077013835A KR 20070089701 A KR20070089701 A KR 20070089701A
Authority
KR
South Korea
Prior art keywords
bdp
days
day
administered
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020077013835A
Other languages
English (en)
Korean (ko)
Inventor
조지 비. 맥도날드
니콜라스 스터지오폴로스
스티브 칸저
Original Assignee
도르 바이오파마, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 도르 바이오파마, 인크. filed Critical 도르 바이오파마, 인크.
Publication of KR20070089701A publication Critical patent/KR20070089701A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Surgery (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020077013835A 2004-12-30 2005-12-30 베클로메타손 디프로피오네이트 및 프레드니손을 이용한이식편대숙주병 및 백혈병의 치료 Ceased KR20070089701A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64017804P 2004-12-30 2004-12-30
US60/640,178 2004-12-30

Publications (1)

Publication Number Publication Date
KR20070089701A true KR20070089701A (ko) 2007-08-31

Family

ID=36615583

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077013835A Ceased KR20070089701A (ko) 2004-12-30 2005-12-30 베클로메타손 디프로피오네이트 및 프레드니손을 이용한이식편대숙주병 및 백혈병의 치료

Country Status (13)

Country Link
US (1) US20060252735A1 (https=)
EP (1) EP1830857B1 (https=)
JP (1) JP2008526773A (https=)
KR (1) KR20070089701A (https=)
CN (2) CN101060848B (https=)
AT (1) ATE481102T1 (https=)
AU (1) AU2005321826B2 (https=)
CA (1) CA2583244A1 (https=)
DE (1) DE602005023655D1 (https=)
DK (1) DK1830857T3 (https=)
IL (1) IL182462A0 (https=)
NZ (1) NZ554326A (https=)
WO (1) WO2006072093A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090143328A1 (en) * 2001-08-13 2009-06-04 Mcdonald George Method of Treating Cancer by Administration of Topical Active Corticosteroids
SG10201704531XA (en) * 2008-12-08 2017-07-28 Soligenix Inc Topically active steroids for use in radiation and chemotherapeutics injury
US20170209447A1 (en) * 2014-08-07 2017-07-27 Nitor Therapeutics Use of PNP Inhibitor to Treat Relapse of Malignancy after Hematopoietic Stem Cell Transplant
CN106236736A (zh) * 2016-09-26 2016-12-21 安徽省逸欣铭医药科技有限公司 二丙酸倍氯米松肠溶缓释片及其制备方法
EP4073100A4 (en) 2019-12-09 2024-02-14 Syndax Pharmaceuticals, Inc. ANTIBODIES FOR TREATING CHRONIC GRAFT VERSUS HOST DISEASE

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096728A (en) * 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
US5747474A (en) * 1996-07-29 1998-05-05 Immune Modulation, Inc. Immunosuppression by administration of N6,N6 -disubstituted cAMP's, analogues thereof, and related nucleosides
US6096731A (en) * 1998-06-24 2000-08-01 Institute For Drug Research, Inc. Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation
US20020086857A1 (en) * 2000-09-15 2002-07-04 Mcdonald George B. Method of long-term treatment of graft-versus-host disease using topical active corticosterioids
AU2002254205B2 (en) * 2001-03-15 2007-05-10 Enteron Pharmaceuticals, Inc. Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
US20030032631A1 (en) 2001-08-13 2003-02-13 Mcdonald George B. Method of treatment of cancer by controlling graft-versus-leukemia using topical active corticosteriods
JP4014912B2 (ja) * 2001-09-28 2007-11-28 株式会社ルネサステクノロジ 半導体装置

Also Published As

Publication number Publication date
WO2006072093A3 (en) 2007-03-22
CN101060848A (zh) 2007-10-24
EP1830857B1 (en) 2010-09-15
EP1830857A4 (en) 2008-02-27
DK1830857T3 (da) 2011-02-07
EP1830857A2 (en) 2007-09-12
NZ554326A (en) 2010-10-29
ATE481102T1 (de) 2010-10-15
AU2005321826A1 (en) 2006-07-06
CA2583244A1 (en) 2006-07-06
JP2008526773A (ja) 2008-07-24
AU2005321826B2 (en) 2012-03-15
US20060252735A1 (en) 2006-11-09
WO2006072093A2 (en) 2006-07-06
DE602005023655D1 (de) 2010-10-28
IL182462A0 (en) 2008-04-13
CN101060848B (zh) 2011-06-22
CN102218070A (zh) 2011-10-19

Similar Documents

Publication Publication Date Title
De Oliveira et al. Clinical presentation and management of mTOR inhibitor-associated stomatitis
Johnston et al. Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease
US20100266590A1 (en) Combination therapy
US20260000714A1 (en) C. novyi for the treatment of solid tumors in non-human animals
EP4653054A2 (en) C. novyi for the treatment of solid tumors in humans
JP2021500377A (ja) 遅延放出デフェリプロン錠剤及びその使用法
Martin et al. Evaluation of oral beclomethasone dipropionate for prevention of acute graft-versus-host disease
US6096731A (en) Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation
TW200835484A (en) Use of a combination of rapamycin or its derivative and pimecrolimus
KR20070089701A (ko) 베클로메타손 디프로피오네이트 및 프레드니손을 이용한이식편대숙주병 및 백혈병의 치료
US20100184732A1 (en) Method of long-term treatment of graft-versus-host disease using topical active corticosteroids
KR20230136603A (ko) S1p 수용체 조정제를 사용한 치료 방법
US6239120B1 (en) Method and means for treating glomerulonephritis
JP2024500752A (ja) Ｃ５ａ阻害剤を用いたｃ３糸球体腎症の治療
EP1056461B1 (en) Glucocorticoids for treating glomerulonephritis
Sanford et al. Enteric-coated mycophenolate sodium: a review of its use in the prevention of renal transplant rejection
CN1901906B (zh) 治疗套细胞淋巴瘤的cci-779
US20220226333A1 (en) Irsogladine for the treatment of eosinophilic gastrointestinal diseases
CN112274511B (zh) 用于治疗移植物抗宿主病的喹啉衍生物
CN118043051A (zh) 用于治疗或预防抗宿主病的吡咯并六元杂芳物
US20020086857A1 (en) Method of long-term treatment of graft-versus-host disease using topical active corticosterioids
US20030032631A1 (en) Method of treatment of cancer by controlling graft-versus-leukemia using topical active corticosteriods
CA2413883C (en) Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation
CN116529241A (zh) 治疗化脓性汗腺炎的方法
WO2013082541A1 (en) Method of preventing acute graft-versus-host disease using oral beclomethasone dipropionate

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20070619

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20101230

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20120904

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20130102

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20120904

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I